XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 1 filers reported holding XENON PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,080,034 | -16.7% | 500,001 | -6.1% | 3.11% | -22.5% |
| Q2 2023 | $20,508,950 | -30.0% | 532,700 | -34.9% | 4.01% | -30.2% |
| Q1 2023 | $29,294,294 | -12.6% | 818,505 | -3.7% | 5.75% | -12.4% |
| Q4 2022 | $33,515,500 | +9.2% | 850,000 | 0.0% | 6.57% | -11.1% |
| Q3 2022 | $30,685,000 | -8.7% | 850,000 | -23.0% | 7.39% | -8.3% |
| Q2 2022 | $33,594,000 | +19.4% | 1,104,334 | +20.0% | 8.06% | +18.5% |
| Q1 2022 | $28,124,000 | -5.2% | 920,000 | -3.2% | 6.80% | +3.1% |
| Q4 2021 | $29,678,000 | +177.5% | 950,000 | +35.7% | 6.59% | +164.8% |
| Q3 2021 | $10,696,000 | – | 700,000 | – | 2.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |